Biofixt SRL
The score of Biofixt shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +69 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biofixt's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 125,702 € | ||||
| Equity | 540,954 € | ||||
| Cash | 119,715 € | ||||
| EBITDA | 203,243 € | ||||
| Total assets | 807,252 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Biofixt's financial analysis
- Solvency67.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biofixt
Biofixt's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0891.084.956
- VAT number
- BE0891084956
- Peppol
- Registered · 0208:0891084956 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Jul 2007
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Biofixt (SRL) has been based in Antwerp since 2007, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 125,702 € and equity of 540,954 €; its revenue is not published. Its solvency stands at 67.0%, above the median of its sector (46.0%).
Companies similar to Biofixt
Companies in the same business, of comparable size and area, outside its group.
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Fysiomed Wholesale of pharmaceutical and medical goods Edegem · balance sheet 663,931 €
- Vifor Fresenius Medical Care Renal Pharma België Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 621,679 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
Frequently asked questions about Biofixt
What is the revenue of Biofixt?
Biofixt files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biofixt?
In Belgium, the VAT number is the company number prefixed with BE: BE0891084956 for Biofixt, if the company is VAT-registered. Its company number (CBE) is 0891.084.956.
Where is the registered office of Biofixt?
According to the CBE register, the registered office of Biofixt is in 2610 Antwerp.
What is the equity of Biofixt?
At the close of the 2025 financial year, the equity of Biofixt amounts to 540,954 €, a solvency of 67.0% of total assets.
Who manages Biofixt?
The register lists 1 active mandates at Biofixt. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biofixt
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →